Colon Neoplasm Clinical Trials

9 recruitingLast updated: June 17, 2026

There are 9 actively recruiting colon neoplasm clinical trials across 8 countries. Studies span Not Applicable, Phase 2, Phase 4. Top locations include Amersfoort, Netherlands, Be’er Ya‘aqov, Israel, Clermont-Ferrand, France. Updated daily from ClinicalTrials.gov.


Colon Neoplasm Trials at a Glance

9 actively recruiting trials for colon neoplasm are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Amersfoort, Be’er Ya‘aqov, and Clermont-Ferrand. Lead sponsors running colon neoplasm studies include Assaf-Harofeh Medical Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Ann-Sofie Backman.

Browse colon neoplasm trials by phase

Treatments under study

About Colon Neoplasm Clinical Trials

Looking for clinical trials for Colon Neoplasm? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Colon Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Colon Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

Colorectal, CancerColo-rectal CancerColon Neoplasm+16 more
San Raffaele University1,200 enrolled4 locationsNCT07450612
Recruiting
Not Applicable

Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients

Colon NeoplasmCancer, LungNeuropathy;Peripheral
University Hospital, Clermont-Ferrand90 enrolled1 locationNCT07427537
Recruiting
Phase 4

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Colon Neoplasm
Assaf-Harofeh Medical Center200 enrolled1 locationNCT05345613
Recruiting

Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer

Rectal NeoplasmsColon NeoplasmsMicrobiota+1 more
Sixth Affiliated Hospital, Sun Yat-sen University300 enrolled1 locationNCT07154173
Recruiting
Not Applicable

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma

Sentinel Lymph NodeIndocyanine Green (ICG)Colon Cancer+9 more
Meander Medical Center341 enrolled1 locationNCT06652672
Recruiting
Phase 2

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Colorectal, CancerColorectal CarcinomaColon Cancer+7 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS25 enrolled3 locationsNCT06640166
Recruiting
Phase 2

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome

Colon CancerColon NeoplasmLynch Syndrome
Ann-Sofie Backman150 enrolled8 locationsNCT04920149
Recruiting
Not Applicable

Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care

Breast NeoplasmProstate NeoplasmColon Neoplasm+1 more
Northwestern University200 enrolled2 locationsNCT06630962
Recruiting
Phase 2

Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer

Colon Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05914389